Bei Akademie registrieren
NTRA, US6323071042

Natera stock heads into November 5 results after oncology data

Published on 11/01/2026 at 17:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Natera stock heads into its November 5 earnings call after fresh oncology data from ESMO. Investors will focus on results and management's outlook.

What Natera Investors Watch Next

  • Natera will discuss third-quarter results on November 5 after the market closes.
  • New Signatera findings from ESMO keep oncology evidence in focus ahead of the call.
  • Management's update may sharpen the market's view of testing growth and the company's outlook.
NTRA, US6323071042, Illustration mit AI erstellt.
NTRA, US6323071042, Illustration mit AI erstellt.

Natera will report its third-quarter results after the market closes on Thursday, November 5, 2026, followed by a conference call at 4:30 p.m. Eastern Time. The company's investor-relations calendar confirms the event and identifies Chief Financial Officer Mike Brophy as the contact. The quarter ended September 30.

The earnings date gives investors a near-term test of Natera's operating momentum. Revenue trends, test volumes and management's outlook are likely to shape how investors assess the company's cell-free DNA diagnostics business, although the company has not yet published the quarter's results.

Oncology Evidence Adds A Second Focus

Natera's October 27 update on the European Society for Medical Oncology Congress said its oncology portfolio featured in 25 abstracts, including 9 oral presentations. The company highlighted results from the phase III VOLGA trial in muscle-invasive bladder cancer and its Signatera Genome Assay. Natera's investor-relations release said the findings were presented at ESMO and included concurrent publications.

At 17:15 CET on Sunday, November 1, Natera stock traded at 371.25 euros on Lang & Schwarz. The real-time quote of Natera stock provides the latest trading view.

Natera stock at a glance

  • Company: Natera, Inc.
  • ISIN: US6323071042
  • Ticker: NTRA
  • Trading venue: Lang & Schwarz
  • Price: 371.25 euros on November 1, 2026, at 17:15 CET

Broader sentiment in U.S. equities will remain relevant for the stock around the earnings event. Current S&P 500 market coverage provides the wider market context.

More news and analyses on Natera stock cover the company's upcoming catalysts and operating developments.

Disclaimer...
en | US6323071042 | NTRA | boerse | 70442154 |